1 completed, 1 suspended, 1 withdrawn. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Suspended 1, Withdrawn 1 |
Follow Exablate BBBD: new trials by email Literature Review of Exablate BBBD trials Research Report on Exablate BBBD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Effectiveness of Blood-Brain Barrier Disruption (BBBD) in Subjects With Suspected Infiltrating Glioma Exablate BBBD - Glioma | Not applicable | Withdrawn | InSightec | 2024-10-23 | 2025-05-02 | |
| ExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating Glioma ExAblate 4000 - Type 2 - Glioma | Not applicable | Suspended | InSightec | 15 | 2023-10-01 | 2022-08-03 |
| Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain Metastases ExAblate BBBD - Breast Cancer, Brain Metastases | Not applicable | Completed | InSightec | 8 | 2019-09-18 | 2026-03-20 |
Glioma (2) · Brain Neoplasms (1) · Breast Neoplasms (1) · Glioblastoma (1)
InSightec (3)
United States (2) · Canada (1)
Graeme Woodworth, MD (2) · Nir Lipsman, MD (1)